Unigestion Holding Sa Gilead Sciences, Inc. Transaction History

Unigestion Holding Sa

$2.06 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $37,195 - $42,926	589 Added 0.4%	146,038 $10 Million
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $42,160 - $51,413	-589 Reduced 0.4%	145,449 $10.7 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $5.29 Million - $6 Million	-72,191 Reduced 33.08%	146,038 $11.8 Million
Q3 2023 Oct 31, 2023	SELL	$73.94 - $80.67 $1.06 Million - $1.16 Million	-14,341 Reduced 6.17%	218,229 $16.4 Million
Q2 2023 Jul 27, 2023	SELL	$76.01 - $86.7 $7.37 Million - $8.4 Million	-96,912 Reduced 29.41%	232,570 $17.9 Million
Q1 2023 May 09, 2023	BUY	$77.31 - $88.08 $1.7 Million - $1.94 Million	22,054 Added 7.17%	329,482 $27.3 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $1.66 Million - $2.38 Million	-26,615 Reduced 7.97%	307,428 $26.4 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $12.3 Million - $14.1 Million	207,411 Added 163.79%	334,043 $21.1 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $2.3 Million - $2.59 Million	39,845 Added 45.91%	126,632 $7.83 Million
Q1 2022 Apr 14, 2022	BUY	$57.92 - $72.58 $5.03 Million - $6.3 Million	86,787 New	86,787 $5.16 Million
Q3 2021 Oct 14, 2021	SELL	$67.69 - $73.03 $1.73 Million - $1.86 Million	-25,521 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$63.47 - $69.35 $69.2 Million - $75.6 Million	-1,090,750 Reduced 97.71%	25,521 $1.73 Million
Q1 2021 May 05, 2021	SELL	$60.0 - $68.46 $27.6 Million - $31.4 Million	-459,377 Reduced 29.15%	1,116,271 $72.1 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $13.1 Million - $14.9 Million	230,919 Added 17.17%	1,575,648 $91.8 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $79.8 Million - $100 Million	1,285,450 Added 2168.47%	1,344,729 $84.9 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $1.57 Million - $1.83 Million	-21,748 Reduced 26.84%	59,279 $4.56 Million
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $1.54 Million - $1.98 Million	-24,651 Reduced 23.33%	81,027 $6.06 Million
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $803,316 - $886,719	-12,851 Reduced 10.84%	105,678 $6.7 Million
Q2 2019 Jul 15, 2019	SELL	$61.87 - $69.38 $1.14 Million - $1.28 Million	-18,422 Reduced 13.45%	118,529 $8.01 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $10.8 Million - $12.1 Million	-172,618 Reduced 55.76%	136,951 $8.9 Million
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $4.6 Million - $6 Million	-76,003 Reduced 19.71%	309,569 $19.4 Million
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $15.1 Million - $16.7 Million	-211,953 Reduced 35.47%	385,572 $29.8 Million
Q2 2018 Jul 24, 2018	BUY	$64.88 - $75.68 $38.8 Million - $45.2 Million	597,525 New	597,525 $42.3 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Unigestion Holding Sa with notifications on news.

Account